![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Grand Forks Human Nutrition Research Center, U.S. Department of Agriculture-ARS, Grand Forks, ND
2To whom correspondence should be addressed. E-mail: gcombs{at}gfhnrc.ars.usda.gov.
Selenium was recognized as a nutritional essential only in the late 1950s. That it might also be anticarcinogenic was first suggested a decade later based on ecological relationships of cancer mortality rates and forage crop Se contents in the United States. Since that time, a substantial body of scientific evidence indicated that Se can, indeed, play a role in cancer prevention. This is supported by a remarkably consistent body of findings from studies with animal tumor and cell culture models, and by some, but not all epidemiologic observations. The body of clinical trial data is less extensive, yet also supportive. The consistent findings from this evidence are that both inorganic and organic Se-compounds can be antitumorigenic at doses greater than those required to support the maximal expression of the selenoenzymes that are generally regarded as discharging the nutritional effects of the element. Although the plausibility of Se as a cancer-protective factor is clear, other research is required to support evidence-based evaluation of this hypothesis. In addition to further, well-planned clinical trials, that research must include the development of analytical tools for speciating Se in foods and biological tissues; the development of better means of assessing Se status in ways that are relevant to cancer prevention; and the determination of the minimal dose of Se that is both safe and effective in reducing cancer risk.
KEY WORDS: • selenium • cancer • health claims
This article has been cited by other articles:
|
|
 |
|
  J. Jayachandran and S. J. Freedland Prevention of Prostate Cancer: What We Know and Where We Are Going American Journal of Men's Health, June 1, 2008; 2(2): 178 - 189. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Meplan, L. K Crosley, F. Nicol, G. W Horgan, J. C Mathers, J. R Arthur, and J. E Hesketh Functional effects of a common single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene: interaction with sex Am. J. Clinical Nutrition, April 1, 2008; 87(4): 1019 - 1027. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Adams A dynamic website for a government/industry-funded project exploring biofortification of wheat with selenium Bioscience Horizons, March 1, 2008; 1(1): 75 - 84. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Meplan, L. K. Crosley, F. Nicol, G. J. Beckett, A. F. Howie, K. E. Hill, G. Horgan, J. C. Mathers, J. R. Arthur, and J. E. Hesketh Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a gender-specific manner (the SELGEN study) FASEB J, October 1, 2007; 21(12): 3063 - 3074. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Aichler, H. Algul, D. Behne, G. Holzlwimmer, B. Michalke, L. Quintanilla-Martinez, J. Schmidt, R. M. Schmid, and M. Brielmeier Selenium status alters tumour differentiation but not incidence or latency of pancreatic adenocarcinomas in Ela-TGF-{alpha} p53+/ mice Carcinogenesis, September 1, 2007; 28(9): 2002 - 2007. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Vogt, R. G. Ziegler, B. H. Patterson, and B. I. Graubard Racial Differences in Serum Selenium Concentration: Analysis of US Population Data from the Third National Health and Nutrition Examination Survey Am. J. Epidemiol., August 1, 2007; 166(3): 280 - 288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Mathers and J. E. Hesketh The Biological Revolution: Understanding the Impact of SNPs on Diet-Cancer Interrelationships J. Nutr., January 1, 2007; 137(1): 253S - 258S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. N. Ames Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage PNAS, November 21, 2006; 103(47): 17589 - 17594. [Abstract] [Full Text] [PDF]
|
|
